BioElectronics Product Cited for "Most Innovative New OTC Product"
From Leading UK-based Healthcare Marketing Publication
FREDERICK, Md., March 11, 2013 /PRNewswire/
-- BioElectronics Corporation (OTC Pink: BIEL), the maker of
unique inexpensive, patented, anti-inflammatory pain reliever
devices announced that the OTC Bulletin, the leading
global trade publication for over-the-counter healthcare
products has chosen its ActiPatch® Musculoskeletal Pain Relief
Therapy as the first runner-up for the "Most Innovative New OTC
Product."
"We are pleased that this award illustrates the progress our
team is making outside the US to establish ActiPatch® as a safe
over-the-counter alternative to drugs," said Rick Staelin, chairman of the board of
BioElectronics and the Edward and Rose Donnell Professor of
Business Administration at The Fuqua School of Business, Duke
University. "ActiPatch® Therapy meets a critical need for
safe pain relief and it is now gaining recognition outside of the
US. We appreciate the opportunity to participate in the OTC
Awards and we are eager to submit our Allay™ Menstrual Pain
Therapy, Smart Insole™ Heel Pain Therapy and other new products
next year."
The OTC Bulletin is widely recognized as
the most comprehensive trade publication for the consumer
healthcare market in more than 45 countries. ActiPatch®
Therapy placed second after Boots Pharmaceuticals Non-Contact
Thermometer product.
A panel of six independent over-the-counter marketing experts
evaluated all twelve nominees from some of the world's leading
pharmaceutical companies. One of the judges, Jerome Reinsten,
former Director-General of the World Self-Medication Industry,
remarked that ActiPatch Therapy was a "novel and previously
unexplored route to topical pain therapy," while another judge felt
the product range was an "ingenious way of providing pain
relief."
The complete details on the award winners are available in the
2013 OTC Awards Supplement
http://www.otc-bulletin.com/awards/pdfs/WinnersSupplement2013.pdf.
About BioElectronics Corporation
Drugs and heat patches provide temporary minimal pain
relief by simply masking it but it always comes back.
ActiPatch provides 5x better pain relief and is 100% safer than
over-the-counter drugs. BioElectronics Corporation is an award
winning medical device developer and manufacturer of advanced
medical devices. Its products are ActiPatch® Therapy, for
over-the-counter treatment of back pain and other musculoskeletal
complaints, the Allay™ menstrual cycle pain therapy, and
RecoveryRx™ for surgical procedures and wound care and HealFast®
Therapy veterinarian line. The unique therapy delivery
system, using patented technology, provides a cost-effective
in-home option to reduce soft tissue pain and inflammation, and to
accelerate healing. For more information, please see
www.bielcorp.com.
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation